Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

DAL

DAL Incorporated is a privately held progressive consulting firm with headquarters based in Orlando, Florida, USA.
Advising the industry since 1980, DAL was formally founded in 1991, by Henry N. Dreifus. DAL has made a name for itself in the smart card and related industries, providing comprehensive services to global clients by identifying and implementing business solutions. DAL provides many services, including competitive market analyses and forecasts, comparative/ gap analyses, complete business case analyses and execution, strategic planning, strategic partnering, technical architecture design, solutions integration, financial advising, application development and implementation strategies.
The DAL client base consists of entrepreneurial and traditional organizations across the world, ranging from start-up companies, and manufacturers, to federal governments, financial institutions, and businesses across every major economic sector. DAL services are tailored to meet the needs of each individual client in a unique and distinguished manner regardless of size, scope or vertical market focus.


Contact Details:
3300 W. Lake Mary Blvd. Suite 300
Lake Mary
Florida
32746
United States of America
Tel:(+1) 407-585-2840
Fax:(+1) 407-531-9932
Email:info@dreifus.com
WWW:

www.dreifus.com/




Loading...

Recent Publications by DAL:

Effect of biomagnetic therapy versus physiotherapy for treatment of knee osteoarthritis: a randomized controlled trial.
OBJECTIVE: To assess the effectiveness of pulsed signal therapy in the...
13th November, 2009
Department of Orthopaedic Surgery (DAL), Centre Hospitalier Universitaire J Rehabil Med. 2009 Nov;41(13):1090-5.
DOI Direct Link
Population health surveillance practice of public health nurses.
OBJECTIVE: To report the population health surveillance functions of...
12th November, 2009
School of Nursing, Faculty of Health Professions, 5869 University Ave, Public Health Nurs. 2009 Nov-Dec;26(6):553-60.
DOI Direct Link
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus.
Diabetes causes approximately 2.9 million deaths yearly, mainly through an...
11th November, 2009
Department of Internal Medicine, University of Perugia, Via E. Dal Pozzo, Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1349-61.
DOI Direct Link
The impact of everyday racism on the occupations of African Canadian women.
BACKGROUND: Occupational therapy has increasingly explored the impact of...
7th November, 2009
School of Occupational Therapy, Dalhousie University, Halifax NS, Canada. Can J Occup Ther. 2009 Oct;76(4):285-93.
Early course of bipolar disorder in high-risk offspring: prospective study.
We studied the course of major mood disorders in the offspring of parents...
3rd November, 2009
MD, Department of Psychiatry, Dalhousie University IWK Health Centre, Br J Psychiatry. 2009 Nov;195(5):457-8.
DOI Direct Link

View more DAL research publications.

Press Releases on DAL:

BioPortfolio Logo
Delta to Turn JFK Tower Pink, Host In-Flight Jam Session 28th September, 2009 Delta Air Lines
ATLANTA, Sept. 28 /PRNewswire-FirstCall/ -- Delta Air Lines (NYSE: DAL) will kick off its fifth year of support for The Breast Cancer Research Foundation (BCRF) Sept. 29 by lighting the New York-JFK
Delta Employees Blanket Salt Lake City Medical Center With Warm Gifts 14th April, 2009 Delta Air Lines
SALT LAKE CITY, April 14 /PRNewswire/ -- Continuing a nine-year tradition of putting a quilt on every sick child's bed, Delta Air Lines (NYSE: DAL) employees today presented Primary Children

BioNews Results for DAL:

US regulator wants more information on Rituxan for CLL
Pharma Times:  Nov 19 2009 10:21PM Matching: dal
Swiss Roche to test Dalcetrapib as atherosclerosis therapy
ADP News:  Nov 18 2009 3:30PM Matching: dal
Medtronic introduces new TSRH 3Dx Spinal System to address multiple pathologies
News-Medical.Net:  Nov 18 2009 5:45AM Matching: dal
Review of Mersana Therapeutics's lead compound, XMT-1001 to be published
News-Medical.Net:  Nov 12 2009 12:48PM Matching: dal
Roche leads soccer Panthers
Prince Edward Island Guardian:  Nov 7 2009 11:07PM Matching: dal
Promote your company here: BioNewsCast - Press Release Distribution

View more DAL news.

DAL Clinical Trials:

Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)

DAL Patents:

US Patent No.Title
7595055 Pharmaceutical composition comprising an extract or compounds isolated from Elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications
5265754 Container for beads and the like
5251943 Pick-up for handicraft items
5112223 Hollow load-bearing universal kiln car refractory modules
4978008 Yarn color organizer for needlecraft project

View more DAL patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 486 individuals from DAL using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 288 times since April 2007, the link to the organisation's website has been followed 48 times

Search for more companies in Lake Mary

Search for more companies in Florida



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for DAL

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.